Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)-Reference-Cited by-同舟云学术

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)

Published:2017-08 Issue:4 Volume:120 Page:588-594
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Washam Jeffrey B.,Hellkamp Anne S.,Lokhnygina Yuliya,Piccini Jonathan P.,Berkowitz Scott D.,Nessel Christopher C.,Becker Richard C.,Breithardt Günter,Fox Keith A.A.,Halperin Jonathan L.,Hankey Graeme J.,Mahaffey Kenneth W.,Singer Daniel E.,Patel Manesh R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

2. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study;Am Heart J,2010

3. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients;Schulman;J Thromb Haemost,2005

4. Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial;Zhang;Biostatistics,2011

5. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions;Wei;J Am Stat Assoc,1989

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH;Blood Reviews;2024-09

2. Diltiazem, direct oral anticoagulants, and risk of major bleeding in patients with atrial fibrillation;Heart Rhythm;2024-06

3. Potential interactions between medications for rate control and direct oral anticoagulants: Population-based cohort and case-crossover study;Heart Rhythm;2024-06

4. Effectiveness and Safety of Different Oral Anticoagulants with P-glycoprotein/ CYP3A4 Inhibitors: A Network Meta-analysis;Current Pharmaceutical Design;2024-04

5. Safety of direct oral anticoagulant use in patients taking verapamil or diltiazem;Heart Rhythm;2023-12